Recent investigations into pig antigen and anti-pig antibody expression

International Journal of Surgery

Volumn 23, Issue , 2015, Pages 223-228

  Byrne, Guerard W ^a,b   McGregor, Christopher G A ^a,b   Breimer, Michael E ^c  

^a MAYO CLINIC   (United States)

^b UNIVERSITY COLLEGE LONDON   (United Kingdom)

^c SAHLGRENSKA ACADEMY AT UNIVERSITY OF GOTHENBURG   (Sweden)

Author keywords

Antibody; Antigen; Non Gal; Xenotransplantation

Indexed keywords

ANTIBODY; ANTIGEN; GALACTOSYLGALACTOSE; GALACTOSYLTRANSFERASE; GGTA 1 ALPHA GALACTOSYLTRANSFERASE; GLYCOLIPID; GLYCOPROTEIN; N ACETYLNEURAMINIC ACID; N ACETYLNEURAMINIC ACID ANTIBODY; UNCLASSIFIED DRUG; DISACCHARIDE; GALACTOSYL-(1-3)GALACTOSE; POLYSACCHARIDE;

BABOON; GRAFT REJECTION; HUMAN; IMMUNOBIOLOGY; NONHUMAN; PATHOGENICITY; PIG; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVIEW; XENOGRAFT; XENOTRANSPLANTATION; ANIMAL; GENETIC ENGINEERING; GENETICS; IMMUNOLOGY; METABOLISM; PRIMATE; PROCEDURES; TRANSGENIC ANIMAL; TRANSPLANTATION;

ANIMALS; ANIMALS, GENETICALLY MODIFIED; ANTIBODIES; DISACCHARIDES; GENETIC ENGINEERING; GRAFT REJECTION; HUMANS; N-ACETYLNEURAMINIC ACID; POLYSACCHARIDES; PRIMATES; SWINE; TRANSPLANTATION, HETEROLOGOUS; TRANSPLANTS;

EID: 84951573769     PISSN: 17439191     EISSN: 17439159     Source Type: Journal    
DOI: 10.1016/j.ijsu.2015.07.724     Document Type: Review

References (54)

1. Mohiuddin M.M., Singh A.K., Corcoran P.C., Hoyt R.F., Thomas M.L., Lewis B.G., et al. One-year heterotopic cardiac xenograft survival in a pig to baboon model. Am. J. Transpl. 2014, 14(2):488-489.
2. Byrne G.W., Azimzadeh A.M., Ezzelarab M., Tazelaar H.D., Ekser B., Pierson R.N., et al. Histopathologic insights into the mechanism of anti-non-Gal antibody-mediated pig cardiac xenograft rejection. Xenotransplantation 2013, 20(5):292-307.
3. Galili U., Shohet S.B., Kobrin E., Stults C.M., Macher B.A. Man, apes, and old world monkeys differ from other mammals in the expression of alpha-Galactosyl epitopes on nucleated cells. J. Biol. Chem. 1988, 263(33):17755-17762.
4. Leventhal J.R., Sakiyalak P., Witson J., Simone P., Matas A.J., Bolman R.M., et al. The synergistic effect of combined antibody and complement depletion on discordant cardiac xenograft survival in nonhuman primates. Transplantation 1993, 57(6):974-978.
5. Diamond L.E., Byrne G.W., Schwarz A., Davis T.A., Adams D.H., Logan J.S. Analysis of the control of the anti-Gal immune response in a non-human primate by galactose alpha-1-3 galactose trisaccharide-polyethylene glycol conjugate. Transplantation 2002, 73(11):1780-1787.
6. Diswall M., Angstrom J., Karlsson H., Phelps C.J., Ayares D., Teneberg S., et al. Structural characterization of alpha1,3-galactosyltransferase knockout pig heart and kidney glycolipids and their reactivity with human and baboon antibodies. Xenotransplantation 2010, 17(1):48-60.
7. Diswall M., Angstrom J., Schuurman H.J., Dor F.J., Rydberg L., Breimer M.E. Studies on glycolipid antigens in small intestine and pancreas from alpha1,3-galactosyltransferase knockout miniature swine. Transplantation 2007, 84(10):1348-1356.
8. Nottle M.B., Beebe L.F., Harrison S.J., McIlfatrick S.M., Ashman R.J., O'Connell P.J., et al. Production of homozygous alpha-1,3-galactosyltransferase knockout pigs by breeding and somatic cell nuclear transfer. Xenotransplantation 2007, 14(4):339-344.
9. Diswall M., Gustafsson A., Holgersson J., Sandrin M.S., Breimer M.E. Antigen-binding specificity of anti-alphaGal reagents determined by solid-phase glycolipid-binding assays. A complete lack of alphaGal glycolipid reactivity in alpha1,3GalT-KO pig small intestine. Xenotransplantation 2011, 18(1):28-39.
10. Dor F.J., Tseng Y.L., Cheng J., Moran K., Sanderson T.M., Lancos C.J., et al. alpha1,3-Galactosyltransferase gene-knockout miniature swine produce natural cytotoxic anti-Gal antibodies. Transplantation 200415, 78(1):15-20.
11. Kuwaki K., Tseng Y.L., Dor F.J., Shimizu A., Houser S.L., Sanderson T.M., et al. Heart transplantation in baboons using alpha1,3-galactosyltransferase gene-knockout pigs as donors: initial experience. Nat. Med. 2005, 11(1):29-31.
12. Lam T.T., Paniagua R., Shivaram G., Schuurman H.J., Borie D.C., Morris R.E. Anti-non-Gal porcine endothelial cell antibodies in acute humoral xenograft rejection of hDAF-transgenic porcine hearts in cynomolgus monkeys. Xenotransplantation 2004, 11(6):531-535.
13. Wu G., Pfeiffer S., Schroder C., Zhang T., Nguyen B.N., Lea W., et al. Co-stimulation blockade targeting CD154 and CD28/B7 modulates the induced antibody response after a pig-to-baboon cardiac xenograft. Xenotransplantation 2005, 12(3):197-208.
14. Byrne G.W., Schirmer J.M., Fass D.N., Teotia S.S., Kremers W.K., Xu H., et al. Warfarin or low-molecular-weight heparin therapy does not prolong pig-to-primate cardiac xenograft function. Am. J. Transpl. 2005, 5(5):1011-1020.
15. Buhler L., Xu Y., Li W., Zhu A., Cooper D.K. An investigation of the specificity of induced anti-pig antibodies in baboons. Xenotransplantation 2003, 10(1):88-93.
16. Chen G., Qian H., Starzl T., Sun H., Garcia B., Wang X., et al. Acute rejection is associated with antibodies to non-Gal antigens in baboons using Gal-knockout pig kidneys. Nat. Med. 2005, 11(12):1295-1298.
17. Shimizu A., Hisashi Y., Kuwaki K., Tseng Y.L., Dor F.J., Houser S.L., et al. Thrombotic microangiopathy associated with humoral rejection of cardiac xenografts from alpha1,3-galactosyltransferase gene-knockout pigs in baboons. Am. J. Pathol. 2008, 172(6):1471-1481.
18. Tazelaar H.D., Byrne G.W., McGregor C.G. Comparison of Gal and non-Gal-mediated cardiac xenograft rejection. Transplantation 2011, 91(9):968-975.
19. Azimzadeh A.M., Byrne G.W., Ezzelarab M., Welty E., Braileanu G., Cheng X., et al. Development of a consensus protocol to quantify primate anti-non-Gal xenoreactive antibodies using pig aortic endothelial cells. Xenotransplantation 2014, 21(6):555-566.
20. Rood P.P., Hara H., Ezzelarab M., Busch J., Zhu X., Ibrahim Z., et al. Preformed antibodies to alpha1,3-galactosyltransferase gene-knockout (GT-KO) pig cells in humans, baboons, and monkeys: implications for xenotransplantation. Transpl. Proc. 2005, 37(8):3514-3515.
21. Saethre M., Baumann B.C., Fung M., Seebach J.D., Mollnes T.E. Characterization of natural human anti-non-gal antibodies and their effect on activation of porcine gal-deficient endothelial cells. Transplantation 2007, 84(2):244-250.
22. van Poll D., Nahmias Y., Soto-Gutierrez A., Ghasemi M., Yagi H., Kobayashi N., et al. Human immune reactivity against liver sinusoidal endothelial cells from GalTalpha(1,3)GalT-deficient pigs. Cell Transplant. 2010, 19(6):783-789.
23. McGregor C.G., Ricci D., Miyagi N., Stalboerger P.G., Du Z., Oehler E.A., et al. Human CD55 expression blocks hyperacute rejection and restricts complement activation in Gal knockout cardiac xenografts. Transplantation 2012, 93(7):686-692.
24. Ezzelarab M., Garcia B., Azimzadeh A., Sun H., Lin C.C., Hara H., et al. The innate immune response and activation of coagulation in alpha1,3-galactosyltransferase gene-knockout xenograft recipients. Transplantation 2009, 87(6):805-812.
25. Le Bas-Bernardet S., Tillou X., Branchereau J., Dilek N., Poirier N., Chatelais M., et al. Bortezomib, C1-inhibitor and plasma exchange do not prolong the survival of multi-transgenic GalT-KO pig kidney xenografts in baboons. Am. J. Transpl. 2015, 15(2):358-370.
26. Cairns T.D.H., Taube D.H., Stevens N., Binns R., Welsh K.I. Xenografts - future prospects for clinical transplantation. Immunol. Lett. 1991, 29:167-170.
27. Breimer M.E., Bjorck S., Svalandr C.T., Bengtsson A., Rydberg L., Lie-Karlsen K., et al. Extracorporeal ("ex vivo") connection of pig kidneys to humans. I. Clinical data and studies of platelet destruction. Xenotransplantation 1996, 3:328-339.
28. Horslen S.P., Hammel J.M., Fristoe L.W., Kangas J.A., Collier D.S., Sudan D.L., et al. Extracorporeal liver perfusion using human and pig livers for acute liver failure. Transplantation 2000, 70(10):1472-1478.
29. Levy M.F., Crippin J., Sutton S., Netto G., McCormack J., Curiel T., et al. Liver allotransplantation after extracorporeal hepatic support with transgenic (hCD55/hCD59) porcine livers. Transplantation 2000, 69(2):272-280.
30. Chari R.S., Collins B.H., Magee J.C., DiMaio M., Kirk A.D., Harland R.C., et al. Brief report: treatment of hepatic failure with ex vivo pig-liver perfusion followed by liver transplantation. N. Engl. J. Med. 1994, 331(4):234-237.
31. Demetriou A.A., Brown R.S., Busuttil R.W., Fair J., McGuire B.M., Rosenthal P., et al. Prospective, randomized, multicenter, controlled trial of a bioartificial liver in treating acute liver failure. Ann. Surg. 2004, 239(5):660-667. discussion 667-670.
32. Yeh P., Ezzelarab M., Bovin N., Hara H., Long C., Tomiyama K., et al. Investigation of potential carbohydrate antigen targets for human and baboon antibodies. Xenotransplantation 2010, 17(3):197-206.
33. Byrne G.W., Stalboerger P.G., Du Z., Davis T.R., McGregor C.G. Identification of new carbohydrate and membrane protein antigens in cardiac xenotransplantation. Transplantation 2011, 91(3):287-292.
34. Byrne G.W., Stalboerger P.G., Davila E., Heppelmann C.J., Gazi M.H., McGregor H.C., et al. Proteomic identification of non-Gal antibody targets after pig-to-primate cardiac xenotransplantation. Xenotransplantation 2008, 15(4):268-276.
35. Byrne G.W., Du Z., Stalboerger P., Kogelberg H., McGregor C.G.A. Cloning and expression of porcine β1,4 N-acetylgalactosaminyl transferase encoding a new xenoreactive antigen. Xenotransplantation 2014, 21:543-554.
36. Bird G.W., Wingham J. Cad(super Sda) in a British family with eastern connections: a note on the specificity of the Dolichos biflorus lectin. J. Immunogenet. 1976, 3(5):297-302.
37. Merbl Y., Zucker-Toledano M., Quintana F.J., Cohen I.R. Newborn humans manifest autoantibodies to defined self molecules detected by antigen microarray informatics. J. Clin. Investig. 2007, 117(3):712-718.
38. Padler-Karavani V., Yu H., Cao H., Chokhawala H., Karp F., Varki N., et al. Diversity in specificity, abundance, and composition of anti-Neu5Gc antibodies in normal humans: potential implications for disease. Glycobiology 2008, 18(10):818-830.
39. Higashi H., Naiki M., Matuo S., Okouchi K. Antigen of "serum sickness" type of heterophile antibodies in human sera: indentification as gangliosides with N-glycolylneuraminic acid. Biochem. Biophys. Res. Commun. 1977, 79(2):388-395.
40. Tahara H., Ide K., Basnet N.B., Tanaka Y., Matsuda H., Takematsu H., et al. Immunological property of antibodies against N-glycolylneuraminic acid epitopes in cytidine monophospho-N-acetylneuraminic acid hydroxylase-deficient mice. J. Immunol. 2010, 184(6):3269-3275.
41. Ohdan H., Yang Y.G., Shimizu A., Swenson K.G., Sykes M. Mixed chimerism induced without lethal conditioning prevents T cell- and anti-Gal alpha 1,3Gal-mediated graft rejection. J. Clin. Investig. 1999, 104(3):281-290.
42. Satake M., Kawagishi N., Kumagai-Braesch M., Samuelsson B.E., Rydberg L., Tibell A., et al. Specificity of human xenoantibodies formed in response to fetal porcine isletlike cell clusters. Transplant. Proc. 1994, 26(3):1122.
43. Kobayashi T., Yokoyama I., Suzuki A., Abe M., Hayashi S., Matsuda H., et al. Lack of antibody production against hanganutziu-deicher (H-D) antigens with N-glycolylneuraminic acid in patients with porcine exposure history. Xenotransplantation 2000, 7:177-180.
44. Blixt O., Kumagai-Braesch M., Tibell A., Groth C.G., Holgersson J. Anticarbohydrate antibody repertoires in patients transplanted with fetal pig islets revealed by glycan arrays. Am. J. Transpl. 2009, 9(1):83-90.
45. Rydberg L., Bjorck S., Hallberg E., Magnusson S., Sumitran S., Samuelsson B.E., et al. Extracorporeal ("ex vivo") connection of pig kidneys to humans. II. The anti-pig antibody response. Xenotransplantation 1996, 3:340-353.
46. Magnusson S., Mansson J.E., Strokan V., Jussila R., Kobayashi T., Rydberg L., et al. Release of pig leukocytes during pig kidney perfusion and characterization of pig lymphocyte carbohydrate xenoantigens. Xenotransplantation 2003, 10(5):432-445.
47. Scobie L., Padler-Karavani V., Le Bas-Bernardet S., Crossan C., Blaha J., Matouskova M., et al. Long-term IgG response to porcine Neu5Gc antigens without transmission of PERV in burn patients treated with porcine skin xenografts. J. Immunol. 2013, 191(6):2907-2915.
48. Burlak C., Wang Z.Y., Chihara R.K., Lutz A.J., Wang Y., Estrada J.L., et al. Identification of human preformed antibody targets in GTKO pigs. Xenotransplantation 2012, 19(2):92-101.
49. Chihara R.K., Lutz A.J., Paris L.L., Wang Z.Y., Sidner R.A., Heyrman A.T., et al. Fibronectin from alpha 1,3-galactosyltransferase knockout pigs is a xenoantigen. J. Surg. Res. 2013, 184(2):1123-1133.
50. Kim Y.G., Gil G.C., Harvey D.J., Kim B.G. Structural analysis of alpha-Gal and new non-Gal carbohydrate epitopes from specific pathogen-free miniature pig kidney. Proteomics 2008, 8(13):2596-2610.
51. Jeong H.J., Adhya M., Park H.M., Kim Y.G., Kim B.G. Detection of Hanganutziu-Deicher antigens in O-glycans from pig heart tissues by matrix-assisted laser desorption/ionization time-of-flight mass spectrometry. Xenotransplantation 2013, 20(6):407-417.
52. Miyagawa S., Takeishi S., Yamamoto A., Ikeda K., Matsunari H., Yamada M., et al. Survey of glycoantigens in cells from alpha1-3galactosyltransferase knockout pig using a lectin microarray. Xenotransplantation 2010, 17(1):61-70.
53. Miyagawa S., Maeda A., Takeishi S., Ueno T., Usui N., Matsumoto S., et al. Lectin array analysis for wild-type and alpha-Gal-knockout pig islets versus healthy human islets. Surg. Today 2013, 43(12):1439-1447.
54. Estrada J.L., Martens G., Li P., Adams A., Newell K.A., Ford M.L., et al. Evaluation of human and non-human primate antibody binding to pig cells lacking GGTA1/CMAH/beta4GalNT2 genes. Xenotransplantation 2015, 22(3):203-210.